Skip to main content
. 2020 Jan 31;2020:4321419. doi: 10.1155/2020/4321419

Table 2.

Variant identified in patients with early-onset gout.

ID Variant Type Frequency (allele count) In silico assessments
gnomAD ExAC ESP 1K Polyphen-2 MutationTaster LRT M-CAP
II:4 c.277C>A, p.L93M Hetero 0.0032% (8) 0.0033% (4) 0 0.04% (2) Damaging Damaging Damaging Possibly pathogenic
III:2 c.277C>A, p.L93M Hetero 0.0032% (8) 0.0033% (4) 0 0.04% (2) Damaging Damaging Damaging Possibly pathogenic